Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  V.KHRN.WT.H | KHRNF | KHRWF

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.


TSXV:KHRN.H - Post by User

Comment by Kyle2020on Apr 18, 2020 11:42am
146 Views
Post# 30925283

RE:RE:running out of funds

RE:RE:running out of fundsthe company is going broke. they are running out of capital, all their revenue related projects are not succeeding - their health services "ilans" in bogota is making money but nothing to justify their valuation or keep their burn rate afloat. At the end of the day there are two options, raise capital dilluting shareprice and putting downward pressure, or they get aquired which could be good or bad for the share price depending on how desperate they become. This has been my opinion all the way down from 3 dollars...and if i could get a nickle from every time i heard someone say how great it would be to buy cheaper shares.....well id be rich. but how has that worked out so far. the big problem is that their burn rate is unsustainable, but worse, they are amateurs. its all good news and marketing but at the end of the day their projections and business model are flawed and badly managed. glta
<< Previous
Bullboard Posts
Next >>